Detalhe da pesquisa
1.
High risk of relapse with intermediate dose cytarabine for consolidation in young favourable-risk acute myeloid leukaemia patients following induction with 7+3: a retrospective multicentre analysis and critical review of the literature.
Br J Haematol
; 194(1): 140-144, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843048
2.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973276
3.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324220
4.
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.
Blood Adv
; 7(24): 7393-7401, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874912
5.
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.
Blood Adv
; 5(23): 5179-5189, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516611
6.
Deep and Prolonged Response to Aurora A Kinase Inhibitor and Subsequently to Nivolumab in MYCL1-Driven Small-Cell Lung Cancer: Case Report and Literature Review.
Case Rep Oncol Med
; 2020: 8026849, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318301
7.
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer.
Cancer Med
; 9(10): 3400-3406, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32189461
8.
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.
J Clin Oncol
; 37(6): 471-480, 2019 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30615550
9.
Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends.
Anticancer Res
; 37(5): 2445-2449, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476812
10.
Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy- a report of two cases.
J Immunother Cancer
; 4: 80, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895919